Domov › Nemalicelični pljučni rak › Kalifornija › Mountain View
Klinične študije za Nemalicelični pljučni rak v Mountain View, CA
21 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Mountain View in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi stran
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi stran
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi stran
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
Vključevanje udeležencevFaza 3
- Stanford University, Stanford · 5 mi stran
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 2
- Stanford Cancer Institute, Stanford · 5 mi stran
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Vključevanje udeležencevOpazovalna študija
- Stanford University, Palo Alto · 5 mi stran
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Vključevanje udeležencevFaza 2
- Stanford Cancer Institute, Stanford · 5 mi stran
- Stanford Hospital and Clinics, Stanford · 5 mi stran
- Stanford Hospital Investigational Drug Services, Stanford · 5 mi stran
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Stanford Cancer Center, Palo Alto · 5 mi stran
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- Stanford Cancer Institute, Stanford · 5 mi stran
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Vključevanje udeležencevFaza 1/2
- Stanford University Medical Center - Neurology, Stanford · 5 mi stran
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi stran
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 1/2
- Stanford Cancer Institute, Stanford · 5 mi stran
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Vključevanje udeležencevFaza 1/2
- Stanford University Medical Center, Stanford · 5 mi stran
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Vključevanje udeležencevFaza 1
- Stanford University Medical Center, Palo Alto · 5 mi stran
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Vključevanje udeležencevFaza 1
- Stanford University, Palo Alto · 5 mi stran
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Vključevanje udeležencevFaza 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi stran
A Study of LY4175408 in Participants With Advanced Cancer
Vključevanje udeležencevFaza 1
- Stanford Medicine Cancer Center, Stanford · 5 mi stran
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- Stanford University, Stanford · 5 mi stran
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Vključevanje udeležencevFaza 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi stran
Engagement of Veterans With Lung Cancer
Vključevanje udeležencev
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi stran
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Stanford · 5 mi stran
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1
- Stanford University, Stanford · 5 mi stran
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Washington, DC55 študij
Druge študije v Mountain View
- Rak (vse vrste)40 študij
- Rak dojke26 študij
- Metastatski rak25 študij
- Akutna mieločna levkemija19 študij
- Rak jajčnikov19 študij
- Motnja avtističnega spektra17 študij
- Rak pljuč17 študij
- Rak prostate15 študij
- Srčno popuščanje15 študij
- Avtizem13 študij
- Akutna limfoblastna levkemija13 študij
- Kolorektalni rak13 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.